Literature DB >> 25036517

IL-23 promotes osteoclastogenesis in osteoblast-osteoclast co-culture system.

Y K Kang1, M C Zhang2.   

Abstract

The aim of this study was to determine the effect of IL-23 on the activity and proliferation of osteoclasts (OC) in co-culture with osteoblasts (OB). OB and OC were individually separated from the skull and femoral bone of a SD rat. OB-OC co-culture with IL-23 added was designed as the experimental group, while the OB-OC co-culture without IL-23 was the control group. In the experimental group, five different concentrations of IL-23 were added, and the cells were then cultured for 24, 48 and 72 h. For each concentration at these three time points, cell proliferation, tartrate-resistant acid phosphatase (TRAP) activity and the lacunae in the bone slices were evaluated, compared with control group at the same time points. Compared to the control group, proliferation and TRAP activity of OC were significantly increased at 24, 48 and 72 h with addition of 0.5 to 10 ng/mL IL-23 (P<0.05). In addition, a dose- and time-dependent correlation between the effect of IL-23 and osteoclastogenesis was noticed though the comparison. Moreover, the area of lacunar resorption in each experimental group was significantly larger than in the control group (P<0.05). In conclusion, IL-23 promotes the proliferation, TRAP activity and bone resorption of OC in OB-OC co-culture.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25036517     DOI: 10.4238/2014.June.18.10

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  10 in total

Review 1.  Mediators of inflammation and bone remodeling in rheumatic disease.

Authors:  Anita T Shaw; Ellen M Gravallese
Journal:  Semin Cell Dev Biol       Date:  2015-10-19       Impact factor: 7.727

2.  Roles of SP600125 in expression of JNK, RANKL and OPG in cultured dental follicle cells.

Authors:  Qi Wang; Xiaojuan Yuan; Boqi Li; Dalei Sun; Jia Liu; Tao Liu; Xiaojuan Bi; Yishan Liu
Journal:  Mol Biol Rep       Date:  2019-03-20       Impact factor: 2.316

Review 3.  Bone Wasn't Built in a Day: Destruction and Formation of Bone in the Rheumatic Diseases.

Authors:  Ellen M Gravallese
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

Review 4.  Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.

Authors:  Rebecca Baum; Ellen M Gravallese
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

5.  Osteogenic Response of MC3T3-E1 and Raw264.7 in the 3D-Encapsulated Co-Culture Environment.

Authors:  Jungju Kim; Hao-Zhen Lyu; Chisung Jung; Kyung Mee Lee; Shi Huan Han; Jae Hyup Lee; Misun Cha
Journal:  Tissue Eng Regen Med       Date:  2021-01-07       Impact factor: 4.169

Review 6.  Regulation of Osteoclast Differentiation by Cytokine Networks.

Authors:  Dulshara Sachini Amarasekara; Hyeongseok Yun; Sumi Kim; Nari Lee; Hyunjong Kim; Jaerang Rho
Journal:  Immune Netw       Date:  2018-02-07       Impact factor: 6.303

7.  Involvement of interleukin‑23 induced by Porphyromonas endodontalis lipopolysaccharide in osteoclastogenesis.

Authors:  Nan Ma; Di Yang; Hirohiko Okamura; Jumpei Teramachi; Tomokazu Hasegawa; Lihong Qiu; Tatsuji Haneji
Journal:  Mol Med Rep       Date:  2016-12-14       Impact factor: 2.952

Review 8.  No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors.

Authors:  Hua Zhang; Han-Lei Jiang; Sheng-Ming Dai
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

Review 9.  From the Clinical Problem to the Basic Research-Co-Culture Models of Osteoblasts and Osteoclasts.

Authors:  Sheng Zhu; Sabrina Ehnert; Marc Rouß; Victor Häussling; Romina H Aspera-Werz; Tao Chen; Andreas K Nussler
Journal:  Int J Mol Sci       Date:  2018-08-03       Impact factor: 5.923

Review 10.  Perspective on skeletal health in inflammatory bowel disease.

Authors:  A A van Bodegraven; N Bravenboer
Journal:  Osteoporos Int       Date:  2019-12-10       Impact factor: 4.507

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.